510(k) · Cleared
ClearedLorenz Biotech Aptiva, Version 2.13
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Lorenz Biotech S.P.A. · GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief
Cleared on Aug 24, 2007 as substantially equivalent to K021755 (Apex Medical Corp., 2002) and 8 other predicates after a 422-day review. Its family tree reaches back 2 generations to 1989.
- Decided
- Aug 24, 2007
- Review
- 422 days
- Class
- Class II
- Product code
- GZJ
- Recalls
- None
- Predicates
- 9
Its longest line of descent runs back 2 generations to K892649 (1989). 22 ancestors in all, the oldest K843924 (1985). No later device cites it as a predicate yet.
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −2 | K892649 | Verimed Myoexorciser Iii (Myo Iii) | Verimed Holdings, Inc. | 1989 | — |
| −1 | K972487 | Emg Retrainer | Chattanooga Group, Inc. | 1997 | — |
| 0 (this device) | K061828 | Lorenz Biotech Aptiva, Version 2.13 | Lorenz Biotech S.P.A. | 2007 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 1985 | 1 | 0 |
| 1987 | 1 | 0 |
| 1991 | 1 | 0 |
| 1992 | 1 | 0 |
| 1993 | 2 | 0 |
| 1994 | 2 | 0 |
| 1995 | 1 | 0 |
| 1997 | 2 | 0 |
| 1998 | 2 | 0 |
| 1999 | 1 | 0 |
| 2001 | 3 | 0 |
| 2002 | 2 | 0 |
| 2003 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in GZJ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new GZJ device
- #1 K252767 actiTENS miniscore 13.1 · 9 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (9)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K021755 | Apex Medical Digital Tens TS1211, TS1212Summary page 1…EDICATE DEVICES Functionality Predicate Device TENS * Apex Medical Digital TENS (K021755) * GEMS-HV TENS (K032994) * Bioscope… | 2002 |
| * | K032994 | GM3 Series HV Tens, Model GM3X3HV (Where X IS Parameter of Different Housing)Summary page 1…Predicate Device TENS * Apex Medical Digital TENS (K021755) * GEMS-HV TENS (K032994) * Bioscope SD TENS (K970249) * Proma… | 2003 |
| * | K970429 | Bioscope SD Tens, Arista SD Plus, AP-102080T Our reading of the summary gave K970249, FDA’s number for Simplex Airbrator (Simplex Medical Systems, Inc.). Corrected to the number with two digits swapped whose FDA name carries the summary’s words for the device, “Bioscope SD TENS”. | 1997 |
| * | K022405 | Modification to Promax-XP, Tens and Microcurrent Device; Promax-Tens, Tens Device…Summary page 1…* GEMS-HV TENS (K032994) * Bioscope SD TENS (K970249) * Promax TENS (K022405) * NeuroTrain III (K003433) Electromyography (EMG)/Biofeedback a EMG Ret… | 2002 |
| * | K003433 | Neuro-Train Iii (3)Summary page 1…* Bioscope SD TENS (K970249) * Promax TENS (K022405) * NeuroTrain III (K003433) Electromyography (EMG)/Biofeedback a EMG Retrainer Dual Channel (K972487)… | 2001 |
| * | K972487 | Emg RetrainerSummary page 1…romax TENS (K022405) * NeuroTrain III (K003433) Electromyography (EMG)/Biofeedback a EMG Retrainer Dual Channel (K972487) a MES-9000/EMG System (K013399) a Sy… | 1997 |
| * | K013399 | Model Mes-9000/Emg SystemSummary page 1…n III (K003433) Electromyography (EMG)/Biofeedback a EMG Retrainer Dual Channel (K972487) a MES-9000/EMG System (K013399) a Synergy System (K981405) Nerve conduction velocity (ENG) Brevio (K0… | 2001 |
| * | K981405 | Synergy LTSummary page 1…iner Dual Channel (K972487) a MES-9000/EMG System (K013399) a Synergy System (K981405) Nerve conduction velocity (ENG) Brevio (K010269) Lorenz Biotech, S.p.A. August 6, 2007… | 1998 |
| * | K012069 | Modification to:Brevio Nerve Conduction Test Instrument Our reading of the summary gave K010269, which is not a number in FDA’s lists. Corrected to the number with two digits swapped whose FDA name carries the summary’s words for the device, “Brevio”. | 2001 |
What descends from it?
No later submission names this one as a predicate yet.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 18 years and passes through 3 companies; a new generation was cleared every 9.9 years on median.
- None of the 22 ancestors has a recall.
- 5 other devices also cite its predicate K021755.
How does its category compare?
All GZJ devicesGZJ Stimulator, Nerve, Transcutaneous, For Pain Relief: FDA decisions, review times, recalls and adverse event reports over 20 years. 2007, this device’s year, is highlighted.
FDA decisions per year · GZJ
1in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · GZJ
207in 2024
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · GZJ
1in 2011
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · GZJ
13in 2025
MAUDE reports naming product code GZJ, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 13 | 223 | 4 | 4 |
| 2008 | 11 | 136 | 1 | 45 |
| 2009 | 16 | 155 | 0 | 17 |
| 2010 | 5 | 232 | 0 | 22 |
| 2011 | 5 | 168 | 1 | 22 |
| 2012 | 12 | 154 | 0 | 20 |
| 2013 | 2 | — | 0 | 10 |
| 2014 | 4 | 344 | 0 | 23 |
| 2015 | 3 | 202 | 0 | 18 |
| 2016 | 3 | 163 | 0 | 32 |
| 2017 | 3 | 113 | 0 | 58 |
| 2018 | 2 | — | 0 | 21 |
| 2019 | 3 | 156 | 0 | 7 |
| 2020 | 4 | 183 | 0 | 10 |
| 2021 | 3 | 231 | 0 | 5 |
| 2022 | 4 | 175 | 0 | 4 |
| 2023 | 1 | — | 0 | 39 |
| 2024 | 3 | 207 | 0 | 12 |
| 2025 | 1 | — | 0 | 13 |
| 2026 | 2 | — | 0 | — |
What is it indicated for?
The Aptiva TM v2.13U is a multifunctional transcutaneous electrical nerve stimulator
(TENS) equipped with a surface electromyography and electroneurography.
Aptiva TM is indicated for symptomatic relief and management of chronic pain, intractable
pain and/or as an adjunctive treatment for the management of post-traumatic pain.
The dynamic surface electromyography and electroneurography system is used for
biofeedback, relaxation training, and muscle re-education as well as monitoring and
display of bioelectric signals produced by muscles, stimulate peripheral nerves, and
monitor and display the electrical activity produced by nerves.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K061828 · printed Nov 4, 2026
Cite this page
510(k) Report. “K061828: Lorenz Biotech Aptiva, Version 2.13.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K061828
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026